Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 1/2019

01-01-2019 | Original Article

Identification of novel variants in neonatal diabetes mellitus genes in Egyptian patients with permanent NDM

Authors: Hanan Madani, Rasha Elkaffas, Badawy Alkholy, Noha Musa, Yomna Shaalan, Rania Elkaffas, Mona Hassan, Mona Hafez, Sarah E Flanagan, Elisa De Franco, Khalid Hussain

Published in: International Journal of Diabetes in Developing Countries | Issue 1/2019

Login to get access

Abstract

Neonatal diabetes mellitus (NDM) is a monogenic form of diabetes resulting from mutations in more than 20 different genes encoding proteins playing a key role in the normal function of the pancreatic beta-cell. Mutations in the genes encoding the ATP-sensitive potassium channel, ABCC8, and KCNJ11 and insulin (INS) gene are the most common causes of NDM; however, in consanguineous populations, EIF2AK3 mutations are more common. Identification of the causative mutations by genetic testing is critical for appropriate management and to guide genetic counseling. To determine the genetic etiology of NDM in diabetic neonates and infants diagnosed before the age of 1 year and to describe their phenotype/genotype characteristics, DNA sequencing of coding regions and intronic boundaries of ABCC8, KCNJ11, INS, and EIF2AK3 genes was undertaken in 20 patients. Further, targeted next-generation sequencing was performed for other genes known to cause NDM. ABCC8 mutations were found in two patients (10%), with compound heterozygous mutations (p.N131 K/p.R598*) in one patient and a homozygous mutation (p.R1554Q) in the another patient. Heterozygous p.A174G and p.V59M mutations of KCNJ11 were identified in two patients (10%), and homozygous EIF2AK3 mutations were identified in two further patients (p.T905fs and p.R653T) (10%). No INS mutations were identified. Further testing identified a SLC19A2 mutation (p.W387*) in one patient (5%) and the same homozygous GCK mutation in two siblings (p.A188T). ABCC8, KCNJ11, and EIF2AK3 mutations were the main genetic causes of permanent NDM among Egyptian neonates.
Literature
1.
go back to reference Carmody D, Støy J, Greeley SA, Bell GI, Philipson LH. A clinical guide to monogenic diabetes. In: Weiss RE, Refetoff S, editors. Genetic diagnosis of endocrine Disorders. 2nd ed. Philadelphia, PA: Elsevier; 2016. p. 19–30. Carmody D, Støy J, Greeley SA, Bell GI, Philipson LH. A clinical guide to monogenic diabetes. In: Weiss RE, Refetoff S, editors. Genetic diagnosis of endocrine Disorders. 2nd ed. Philadelphia, PA: Elsevier; 2016. p. 19–30.
2.
go back to reference Ellard S, Lango Allen H, de Franco E, Flanagan SE, Hysenaj G, Colclough K, et al. Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. Diabetologia. 2013;56:1958–63.CrossRefPubMedPubMedCentral Ellard S, Lango Allen H, de Franco E, Flanagan SE, Hysenaj G, Colclough K, et al. Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. Diabetologia. 2013;56:1958–63.CrossRefPubMedPubMedCentral
3.
go back to reference De Franco E, et al. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet. 2015;386:957–63.CrossRefPubMedPubMedCentral De Franco E, et al. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet. 2015;386:957–63.CrossRefPubMedPubMedCentral
4.
go back to reference Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab. 2008;4:200–13.CrossRefPubMed Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab. 2008;4:200–13.CrossRefPubMed
5.
go back to reference Njolstad PR, et al. Permanent neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med. 2001;344:1588–92.CrossRefPubMed Njolstad PR, et al. Permanent neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med. 2001;344:1588–92.CrossRefPubMed
6.
go back to reference Onal H, et al. Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness. Turk J Pediatr. 2009;51(3):301–4.PubMed Onal H, et al. Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness. Turk J Pediatr. 2009;51(3):301–4.PubMed
7.
go back to reference Greeley SA, Tucker SE, Naylor RN, Bell GI, Philipson H. Neonatal diabetes mellitus: a model for personalized medicine. NIH Public Access. 2011;21(8):464–72. Greeley SA, Tucker SE, Naylor RN, Bell GI, Philipson H. Neonatal diabetes mellitus: a model for personalized medicine. NIH Public Access. 2011;21(8):464–72.
8.
go back to reference Rubio-Cabezas O, Patch AM, Minton JA, Flanagan SE, Edghill EL, Hussain K, et al. Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families. J Clin Endocrinol Metab. 2009;94(11):4162–70.CrossRefPubMedPubMedCentral Rubio-Cabezas O, Patch AM, Minton JA, Flanagan SE, Edghill EL, Hussain K, et al. Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families. J Clin Endocrinol Metab. 2009;94(11):4162–70.CrossRefPubMedPubMedCentral
9.
go back to reference Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med. 2006;355:467–77.CrossRefPubMed Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med. 2006;355:467–77.CrossRefPubMed
10.
go back to reference American Diabetes Association(ADA). Standards of medical care in diabetes. Diabetes Care. 2013;36(1):S11–66.CrossRef American Diabetes Association(ADA). Standards of medical care in diabetes. Diabetes Care. 2013;36(1):S11–66.CrossRef
11.
go back to reference Ellard S, Flanagan SE, Girard CA, Patch AM, Harries LW, Parrish A, et al. Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects. Am J Hum Genet. 2007;81(2):375–82.CrossRefPubMedPubMedCentral Ellard S, Flanagan SE, Girard CA, Patch AM, Harries LW, Parrish A, et al. Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects. Am J Hum Genet. 2007;81(2):375–82.CrossRefPubMedPubMedCentral
12.
go back to reference Klupa T, Edghill EL, Nazim J, Sieradzki J, Ellard S, Hattersley AT, et al. The identification of a R201H mutation in KCNJ11 which encodes Kir 6.2, and successful transfer to sustained release sulfonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of beta cell function among carriers of the R201H mutation. Diabetologia. 2005;48(5):1029–31.CrossRefPubMed Klupa T, Edghill EL, Nazim J, Sieradzki J, Ellard S, Hattersley AT, et al. The identification of a R201H mutation in KCNJ11 which encodes Kir 6.2, and successful transfer to sustained release sulfonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of beta cell function among carriers of the R201H mutation. Diabetologia. 2005;48(5):1029–31.CrossRefPubMed
13.
go back to reference Moritani M, Yokota I, Tsubouchi K, Takaya R, Takemoto K, Minamitani K, et al. Identification of INS and KCNJ11 gene mutations in type 1B diabetes in Japanese children with onset of diabetes before 5 years of age. Pediatr Diabetes. 2013;14(2):112–20.CrossRefPubMed Moritani M, Yokota I, Tsubouchi K, Takaya R, Takemoto K, Minamitani K, et al. Identification of INS and KCNJ11 gene mutations in type 1B diabetes in Japanese children with onset of diabetes before 5 years of age. Pediatr Diabetes. 2013;14(2):112–20.CrossRefPubMed
14.
go back to reference Rubio-Cabezas O, Hattersley AT, Njølstad PR, Mlynarski W, Ellard S, White N, et al. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2014;15(20):47–64.CrossRefPubMed Rubio-Cabezas O, Hattersley AT, Njølstad PR, Mlynarski W, Ellard S, White N, et al. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2014;15(20):47–64.CrossRefPubMed
15.
go back to reference Rubio-Cabezas O, Flanagan SE, Damhuis A, Hattersley AT, Ellard S. KATP channel mutations in infants with permanent diabetes diagnosed after 6 months of life. Pediatr Diabetes. 2012;13:322–5.CrossRefPubMed Rubio-Cabezas O, Flanagan SE, Damhuis A, Hattersley AT, Ellard S. KATP channel mutations in infants with permanent diabetes diagnosed after 6 months of life. Pediatr Diabetes. 2012;13:322–5.CrossRefPubMed
16.
go back to reference Mohnike K, Wieland I, Barthlen W, Vogelgesang S, Empting S, Mohnike W, et al. Clinical and genetic evaluation of patients with KATP channel mutations from the German registry for congenital hyperinsulinism. Horm Res Pediatr. 2014;81(3):156–68.CrossRef Mohnike K, Wieland I, Barthlen W, Vogelgesang S, Empting S, Mohnike W, et al. Clinical and genetic evaluation of patients with KATP channel mutations from the German registry for congenital hyperinsulinism. Horm Res Pediatr. 2014;81(3):156–68.CrossRef
17.
go back to reference Suzuki S, Makita Y, Mukai T, Matsuo K, Ueda O, Fujieda K. Molecular basis of neonatal diabetes in Japanese patients. J Clin Endocrinol Metab. 2007;92:3979–85.CrossRefPubMed Suzuki S, Makita Y, Mukai T, Matsuo K, Ueda O, Fujieda K. Molecular basis of neonatal diabetes in Japanese patients. J Clin Endocrinol Metab. 2007;92:3979–85.CrossRefPubMed
18.
go back to reference Temple IK, Shield JP. 6q24 transient neonatal diabetes. Rev Endocr Metab Disord. 2010;11(3):199–204.CrossRefPubMed Temple IK, Shield JP. 6q24 transient neonatal diabetes. Rev Endocr Metab Disord. 2010;11(3):199–204.CrossRefPubMed
19.
go back to reference Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med. 2004;350(18):1838–49.CrossRefPubMed Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med. 2004;350(18):1838–49.CrossRefPubMed
20.
go back to reference Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes. 2005;54(9):2503–13.CrossRefPubMed Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes. 2005;54(9):2503–13.CrossRefPubMed
21.
go back to reference Madani HA, Fawzy N, Afif S, Abdelghaffar S, Gohar N. Study of KCNJ11 gene mutations in association with monogenic diabetes of infancy and response to sulfonylurea treatment in a cohort study in Egypt. Acta Endocrinologica (Buc). 2016;XII(2):157–60.CrossRef Madani HA, Fawzy N, Afif S, Abdelghaffar S, Gohar N. Study of KCNJ11 gene mutations in association with monogenic diabetes of infancy and response to sulfonylurea treatment in a cohort study in Egypt. Acta Endocrinologica (Buc). 2016;XII(2):157–60.CrossRef
22.
go back to reference Banka S, de Goede C, Yue WW, Morris AAM, von Bremen B, Chandler KE, et al. Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: a treatable neurological disorder caused by TPK1 mutations. Mol Genet Metab. 2014;113(4):301–6.CrossRefPubMed Banka S, de Goede C, Yue WW, Morris AAM, von Bremen B, Chandler KE, et al. Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: a treatable neurological disorder caused by TPK1 mutations. Mol Genet Metab. 2014;113(4):301–6.CrossRefPubMed
23.
go back to reference Mikstiene V, Songailiene J, Byckova J, Rutkauskiene G, Jasinskiene E, Verkauskiene R, et al. Thiamine responsive megaloblastic anaemia syndrome: a novel homozygous SLC19A2gene mutation identified. Am J Med Genet A. 2015;167(7):1605–9.CrossRefPubMed Mikstiene V, Songailiene J, Byckova J, Rutkauskiene G, Jasinskiene E, Verkauskiene R, et al. Thiamine responsive megaloblastic anaemia syndrome: a novel homozygous SLC19A2gene mutation identified. Am J Med Genet A. 2015;167(7):1605–9.CrossRefPubMed
24.
go back to reference Aycan Z, Baş VN, Çetinkaya S, Ağladioğlu SY, Kendirci HNP, Şenocak F. Thiamine-responsive megaloblastic anemia syndrome with atrial standstill: a case report. J Pediatr Hematol Oncol. 2011;33(2):144–7.CrossRefPubMed Aycan Z, Baş VN, Çetinkaya S, Ağladioğlu SY, Kendirci HNP, Şenocak F. Thiamine-responsive megaloblastic anemia syndrome with atrial standstill: a case report. J Pediatr Hematol Oncol. 2011;33(2):144–7.CrossRefPubMed
25.
go back to reference Rubio-Cabezas O, Klupa T, Malecki MT, CEED3 Consortium. Permanent neonatal diabetes mellitus-the importance of diabetes differential diagnosis in neonates and infants. Eur J Clin Investig. 2011;41(3):323–33.CrossRef Rubio-Cabezas O, Klupa T, Malecki MT, CEED3 Consortium. Permanent neonatal diabetes mellitus-the importance of diabetes differential diagnosis in neonates and infants. Eur J Clin Investig. 2011;41(3):323–33.CrossRef
26.
go back to reference Thomson, et al. Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY). Hum Mutat. 2003;22:417–22.CrossRefPubMed Thomson, et al. Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY). Hum Mutat. 2003;22:417–22.CrossRefPubMed
Metadata
Title
Identification of novel variants in neonatal diabetes mellitus genes in Egyptian patients with permanent NDM
Authors
Hanan Madani
Rasha Elkaffas
Badawy Alkholy
Noha Musa
Yomna Shaalan
Rania Elkaffas
Mona Hassan
Mona Hafez
Sarah E Flanagan
Elisa De Franco
Khalid Hussain
Publication date
01-01-2019
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 1/2019
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-018-0658-6

Other articles of this Issue 1/2019

International Journal of Diabetes in Developing Countries 1/2019 Go to the issue